Marigold Investment Management invests in early stage Scandinavian spinouts primarily therapeutics and platforms. From our first fund of $50M, we are investing $1-3M to incorporate these companies and moving towards exit at Phase I, licensing deals/acquisition, or future investment from Marigold and its investment syndication partners. Our first three investment have been made.